Journal for ImmunoTherapy of Cancer (Nov 2021)
753 InhibigenTM administration promotes aberrant T cell responses in cancer but may be beneficial for amelioration of autoimmune disease
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)